m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00302)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
JUNB
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | ARPE-19 cell line | Homo sapiens |
Treatment: shMETTL3 ARPE-19 cells
Control: shControl ARPE-19 cells
|
GSE202017 | |
Regulation |
|
logFC: -8.92E-01 p-value: 4.99E-05 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between JUNB and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 2.95E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | m6A methyltransferase METTL3 is indispensable for TGF-beta-induced EMT of lung cancer cells through the regulation of Transcription factor JunB (JUNB). | |||
Target Regulation | Up regulation | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Pathway Response | Cytokine-cytokine receptor interaction | hsa04060 | ||
Cell Process | Epithelial-mesenchymal transition | |||
In-vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 |
LC-2/ad | Lung adenocarcinoma | Homo sapiens | CVCL_1373 | |
Wilms tumor 1-associating protein (WTAP) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by WTAP | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: WTAP-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: -8.45E-01 p-value: 6.62E-13 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
Response Summary | MeRIP-Seq of mRNAs of MCF7 with or without treated by TGF-beta showed that mRNA with upregulated m6A modification level after TGF-beta treatment were enriched in TGF-beta signaling pathway. Phosphorylated level of SMAD2 or SMAD3 induced by TGF-beta was impaired when WTAP was silenced. The m6A modification and mRNA level of Transcription factor JunB (JUNB), which is known as a cell cycle inhibitor, both were increased after induction of TGF-beta and decreased after knockdown of WTAP. Phosphorylated level of SMAD2 or SMAD3 induced by TGF-beta was impaired when WTAP was silenced. | |||
Target Regulation | Up regulation | |||
Pathway Response | TGF-beta signaling pathway | hsa04350 | ||
Cell cycle | hsa04110 | |||
Cell Process | Arrest cell cycle at G1 phase | |||
Cell apoptosis | ||||
In-vitro Model | MCF-7 | Invasive breast carcinoma | Homo sapiens | CVCL_0031 |
MDA-MB-231 | Breast adenocarcinoma | Homo sapiens | CVCL_0062 | |
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | m6A methyltransferase METTL3 is indispensable for TGF-beta-induced EMT of lung cancer cells through the regulation of Transcription factor JunB (JUNB). | |||
Responsed Disease | Lung cancer [ICD-11: 2C25] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Cytokine-cytokine receptor interaction | hsa04060 | ||
Cell Process | Epithelial-mesenchymal transition | |||
In-vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 |
LC-2/ad | Lung adenocarcinoma | Homo sapiens | CVCL_1373 | |
References